| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2839725 | Clínica e Investigación en Arteriosclerosis | 2012 | 9 Pages |
Abstract
These findings indicate that the PPARβ/δ agonist GW501516 prevents IL-6-induced STAT3 activation by inhibiting ERK1/2 phosphorylation. These effects of GW501516 may contribute to the prevention of cytokine-induced insulin resistance in hepatic cells.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Physiology
Authors
LucÃa Serrano-Marco, Liliane Michalik, Walter Wahli, Manuel Vázquez-Carrera,